Neumora Therapeutics, Inc. (NMRA)
2.595
-0.04
(-1.70%)
USD |
NASDAQ |
Mar 19, 11:11
Neumora Therapeutics Total Liabilities (Quarterly) : 45.67M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| Protalix Biotherapeutics, Inc. | 34.12M |
| Nautilus Biotechnology, Inc. | 34.14M |
| Ventyx Biosciences, Inc. (DELISTED) | 20.10M |
| ProKidney Corp. | 33.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 177.83M |
| Shareholders Equity (Quarterly) | 132.16M |
| Debt to Equity Ratio | 0.152 |
| Current Ratio | 6.852 |
| Net Debt Paydown Yield | -1.12% |